CD68 and breast cancer: Compared to the BC group, the BC+Kaem group showed significantly higher proportions of CD8+/INFγ+, CD49b+/CD107a+, and CD68+/INFγ+ cells in the peripheral blood, while these proportions were lower in the LLC group.